We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
DELISTED
Alliance Healthcare Services
AIQ
| $73K | ﹤0.01% |
10,656
-1,441
| -12% | -$8.97K |
2016 Q2
1 quarter
|
|
2802
Armour Residential REIT
ARR
$1.81B
| $71K | ﹤0.01% |
634
-5,804
| -90% | -$633K |
2016 Q2
1 quarter
|
|
2803
Harvard Bioscience
HBIO
$38.6M
| $71K | ﹤0.01% |
2,616
| – | – |
2016 Q2
1 quarter
|
|
2804
Equity Bancshares
EQBK
$979M
| $70K | ﹤0.01% |
+2,685
| New | +$63.8K |
2016 Q3
0 quarters
|
|
2805
SM Energy
SM
$9.18B
| $68K | ﹤0.01% |
1,761
-1,114
| -39% | -$35.7K |
2016 Q2
1 quarter
|
|
|
JONE
2806
DELISTED
Jones Energy, Inc.
JONE
| $68K | ﹤0.01% |
1,033
| – | – |
2016 Q2
1 quarter
|
|
|
EGLT
2807
DELISTED
Egalet Corporation
EGLT
| $68K | ﹤0.01% |
8,900
| – | – |
2016 Q2
1 quarter
|
|
2808
Fate Therapeutics
FATE
$248M
| $67K | ﹤0.01% |
21,550
-59,054
| -73% | -$143K |
2016 Q2
1 quarter
|
|
|
CGRN
2809
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $66K | ﹤0.01% |
4,840
| – | – |
2016 Q2
1 quarter
|
|
|
FOE
2810
DELISTED
Ferro Corporation
FOE
| $66K | ﹤0.01% |
4,771
-4,771
| -50% | -$63K |
2016 Q2
1 quarter
|
|
2811
Fossil Group
FOSL
$399M
| $65K | ﹤0.01% |
2,350
-2,660
| -53% | -$78.6K |
2016 Q2
1 quarter
|
|
|
HABT
2812
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $62K | ﹤0.01% |
4,439
-21,079
| -83% | -$325K |
2016 Q2
1 quarter
|
|
2813
Dawson Geophysical
DWSN
$66.8M
| $61K | ﹤0.01% |
+8,366
| New | +$59.6K |
2016 Q3
0 quarters
|
|
|
LEJU
2814
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $60K | ﹤0.01% |
1,126
| – | – |
2016 Q2
1 quarter
|
|
2815
Ubiquiti
UI
$36.9B
| $59K | ﹤0.01% |
1,100
-3,600
| -77% | -$173K |
2016 Q2
1 quarter
|
|
|
XRM
2816
DELISTED
Xerium Technologies Inc (new)
XRM
| $59K | ﹤0.01% |
+7,400
| New | +$58.9K |
2016 Q3
0 quarters
|
|
|
NCOM
2817
DELISTED
National Commerce Corporation
NCOM
| $57K | ﹤0.01% |
2,100
| – | – |
2016 Q2
1 quarter
|
|
2818
New York Times
NYT
$11.1B
| $56K | ﹤0.01% |
4,667
-85,230
| -95% | -$1.08M |
2016 Q2
1 quarter
|
|
2819
Precigen
PGEN
$2.36B
| $56K | ﹤0.01% |
2,011
-12,532
| -86% | -$331K |
2016 Q2
1 quarter
|
|
|
SRGA
2820
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $56K | ﹤0.01% |
599
+439
| +274% | +$44K |
2016 Q2
1 quarter
|
|
|
TLRA
2821
DELISTED
Telaria, Inc.
TLRA
| $56K | ﹤0.01% |
33,250
| – | – |
2016 Q2
1 quarter
|
|
|
APOL
2822
DELISTED
Apollo Education Group Inc Class A
APOL
| $56K | ﹤0.01% |
7,000
| – | – |
2016 Q2
1 quarter
|
|
2823
Immunic
IMUX
$102M
| $55K | ﹤0.01% |
22
-18
| -45% | -$44.4K |
2016 Q2
1 quarter
|
|
2824
Ingles Markets
IMKTA
$1.62B
| $54K | ﹤0.01% |
1,353
-1,675
| -55% | -$64.4K |
2016 Q2
1 quarter
|
|
2825
Chemung Financial Corp
CHMG
$394M
| $53K | ﹤0.01% |
+1,827
| New | +$54.3K |
2016 Q3
0 quarters
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.